Nanoparticle-based immunopotentiation via tetanus toxoid-loaded gelatin and aminated gelatin nanoparticles

Drug Delivery

Volumn 18, Issue 5, 2011, Pages 320-330

  Sudheesh, M S ^a   Vyas, S P ^a   Kohli, D V ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Biodegradable polymers; Controlled release; Immunoadjuvants; Particulate carriers; Vaccine delivery

Indexed keywords

GAMMA INTERFERON; GELATIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 2; NANOCARRIER; TETANUS TOXOID;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG CONJUGATION; FEMALE; IMMUNOGENICITY; IMMUNOPOTENTIATION; IMMUNOSTIMULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; FEMALE; GELATIN; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; NANOPARTICLES; PARTICLE SIZE; TETANUS TOXOID; TH1 CELLS; TH2 CELLS;

EID: 79958230714     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2010.549525     Document Type: Article

References (37)

1. Aguilar, J.C., Rodriguez, E.G. (2007). Vaccine adjuvants revisited. Vaccine. 25:3752-62 (Pubitemid 46589757)
2. Allison, A.C., Byars N.E. (1991). Immunological adjuvants: desirable properties and side-effects. Mol Immunol. 28:279-84
3. Aprile, M.A., Wardlaw, A.C. (1966). Aluminum compounds as adjuvants for vaccine and toxoids in man: a review. Can J Pub Health. 57:343-54
4. Clemmenson, O., Knudsen, H.E. (1980). Contact sensitivity to aluminium in a patient hyposensitized with aluminium precipitated grass pollen. Contact Dermatitis. 6:305-8 (Pubitemid 11254869)
5. Coester, C., Nayyar, P., Samuel, J. (2006). In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localization. Eur J Pharm Biopharm. 62:306-14
6. Coester, C.J., Langer, K., Von Briesen, H., Kreuter, J. (2000). Gelatin nanoparticles by two step desolvation - a new preparation method, surface modifications and cell uptake. J Microencapsul. 17:187-93 (Pubitemid 30135796)
7. Collier, L.H., Polakoff, S., Mortimer, J. (1979). Reactions and antibody responses to reinforcing doses of adsorbed and plain tetanus vaccines. Lancet. 1:1364-8
8. Copland, M.J., Baird, M.A., Rades, T., McKenzie, J.L., Becker, B., Reckd, F., Tyler, P.C., Davies, N.M. (2003). Liposomal delivery of antigen to human dendritic cells. Vaccine. 21:883-90 (Pubitemid 36126422)
9. Erodohazi, M., Newman, R.L. (1971). Aluminium hydroxide granuloma. Br Med J. 3:621-3
10. Fields, R. (1971). The measurement of amino groups in proteins and peptides. Biochem J. 124:581-90
11. Foged, C., Brodin, B., Frokjaer, S., Sundblad, A. (2005). Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm. 298:315-22 (Pubitemid 40910735)
12. Frost, L., Johansen, P., Pedersen, S., Veien, N., Ostergaard, P.A., Nielsen, M.H. (1985). Persistent subcutaneous nodules in children hyposensitized with aluminium-containing allergen extracts. Allergy. 40:368-72 (Pubitemid 15042355)
13. Gupta, R.K., Chang, A.C., Griffin, P., Rivera, R., Siber, G.R. (1996). In vivo distribution of radioactivity in mice after injection of biodegradable polymer nanoparticles containing 14C-labeled tetanus toxoid. Vaccine. 14:1412-6 (Pubitemid 27010310)
14. Jaganathan, K.S., Rao, Y.U.B., Singh, P., Prabakaran, D., Gupta, S., Jain, A., Vyas, S.P. (2005). Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(d,l-lactic-co-glycolic acid) versus chitosan microspheres. Int J Pharm. 294:23-32 (Pubitemid 40462320)
15. Jameela, S.R., Jayakrishnan, A. (1995). Glutaraldehyde crosslinked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle. Biomaterials. 16:769-75
16. Johnson, W.C., Jr. (1995). Secondary structure of proteins through circular dichroism spectroscopy. Annu Rev Biophys Biophys Chem. 14:145-66
17. Kuijpers, A.J., Engbers, G.H., Krijgsveld, J., Zaat, S.A., Dankert, J., Feijen, J. (2000). Crosslinking and characterisation of gelatin matrices for biomedical applications. J Biomaterials Sci Polym Edi. 3:225-43 (Pubitemid 30243023)
18. Kwon, Y.J., Standley, S.M., Goh, S.L., Frechet, J.M.H. (2005). Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles. J Contr Rel. 105:199-212 (Pubitemid 40941986)
19. Matsuhasi, T., Ikegami, H. (1982). Elevation of levels of IgE antibody to tetanus toxin in individuals vaccinated with diphtheria-pertussistetanus vaccine. J Infect Dis. 146:290 (Pubitemid 12009799)
20. Nagel, J., Svec, D., Water, T., Fireman, P. (1977). IgE synthesis in man I. Development of specific IgE antibodies after immunization with tetanus-diphtheria (TD) toxoids. J Immunol. 18:334-41 (Pubitemid 8028548)
21. Nakane, A., Numata, A., Minagawa, T. (1992). Endogenous tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice. Infect Immun. 60:523-8
22. Nakaoka, R., Tabata, Y., Ikada, Y. (1995). Potentiality of gelatin microsphere as immunological adjuvant. Vaccine. 13:653-61
23. Nixon, A., Zaghouani, H., Penney, C.L., Lacroix, M., Dionne, G., Anderson, S.A., Kennedy, R.C., Bona, C.A. (1992). Adjuvanticity of stearyl tyrosine on the antibody response to peptide 503-535 from HIV gp160. Viral Immunol. 59:141-50
24. Oussoren, C., Storm, G. (2001). Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev. 50:143-56 (Pubitemid 32727280)
25. Raghuvanshi, R.S., Goyal, S., Singh, O., Panda, A.K. (1998). Stabilization of dichloromethane-induced protein denaturation during microencapsulation. Pharm Dev Technol. 3:269-76 (Pubitemid 28310943)
26. Raychaudhuri, S., Rock, K.L. (1998). Fully mobilizing host defense: building better vaccines. Nat Biotechnol. 11:1025-31 (Pubitemid 128723949)
27. Reece, J.C., Vardaxis, N.J., Marshall, J.A., Crowe, S.M., Cameron, P.U. (2001). Uptake of HIV and latex particles by fresh and cultured dendritic cells and monocytes. Immunol Cell Biol. 79:255-63 (Pubitemid 32522174)
28. Rubino, O.P., Kowalsky, R., Swarbrick, J. (1993). Albumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking, and drug release. Pharm Res. 10:1059-65 (Pubitemid 23211432)
29. Schirmbeck, R., Melber, K., Mertens, T., Reimann J. (1994). Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implications for the pathogenesis of HBV-induced hepatitis. J Virol. 68:1418-25 (Pubitemid 24065703)
30. Seki, T., Kanbayashi, H., Nagao, T., Chono, S., Tomita, M., Hayashi, M., Tabata, Y. (2005). Effect of aminated gelatin on the nasal absorption of insulin in rats. Biol Pharm Bull. 28:510-4 (Pubitemid 40879978)
31. Singh, M., O'Hagan D.T. (2002). Recent advances in vaccine adjuvants. Pharm Res. 6:715-28 (Pubitemid 34686729)
32. Tabata, Y., Ikada, Y. (1998). Protein release from gelatin matrixes. Adv Drug Del Rev. 3:287-301
33. Traquina, P., Morandi, M., Contorni, M., Van Nest, G. (1996). MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates. J Infect Dis. 174: 168-75
34. Tzafriri, A.R., Bercovier, M., Parnas, H. (2002). Reaction diffusion model of the enzymatic erosion of insoluble fibrillar matrices. Biophys J. 83:776-93 (Pubitemid 34803616)
35. Vassilev, T.L. (1978). Aluminium phosphate but not calcium phosphate stimulates the specific IgE response in guinea-pigs to tetanus toxoid. Allergy. 33:155-9 (Pubitemid 9014040)
36. Weber, C., Coester, C., Kreuter, J., Langer, K. (2000). Desolvation process and surface characterization of protein nanoparticles. Int J Pharm. 194:91-102
37. White, R.G., Coons, A.H., Connolly, J.M. (1955). Studies on antibody production III - The alum granuloma. J Exp Med. 102: 73-82